Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
- PMID: 2247442
- PMCID: PMC55034
- DOI: 10.1073/pnas.87.22.8736
Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
Abstract
Although hematopoiesis is known to originate in a population of very primitive cells with both lymphopoietic and myelopoietic potential, a procedure for enumerating such cells has to date not been available. We now describe a quantitative assay for long-term repopulating stem cells with the potential for reconstituting all hematopoietic lineages. This assay has two key features. The first is the use of competitive repopulation conditions that ensure not only the detection of a very primitive class of hematopoietic stem cells but also the survival of lethally irradiated mice transplanted with very low numbers of such cells. The second is the use of a limiting-dilution experimental design to allow stem cell quantitation. The assay involves transplanting limiting numbers of male "test" cells into lethally irradiated syngeneic female recipients together with 1-2 x 10(5) syngeneic female marrow cells whose long-term repopulating ability has been compromised by two previous cycles of marrow transplantation. The proportion of assay recipients whose regenerated hematopoietic tissues are determined to contain greater than or equal to 5% cells of test cell origin (male) greater than or equal to 5 weeks later is then used to calculate the frequency of competitive repopulating units (CRU) in the original male test cell suspension (based on Poisson statistics). Investigation of this assay system has shown that all three potential sources of stem cells (test cells, compromised cells, and the host) can under appropriate circumstances contribute to long-term hematopoietic regeneration, thus establishing both the competitive pressure of hematopoietic stem cells in the cotransplanted compromised population and in the host, and the need to use genetic markers to track the specific contribution of the injected test cells. Analysis of the frequency of CRU in test marrow suspensions that varied widely in their CRU content gave similar values when endpoints of either 5 or 10 weeks posttransplantation were used and when either recipient marrow or thymus was used to identify progeny populations. In addition, repopulation of marrow and thymus was found to be associated in most mice injected with limiting numbers of test cells. These findings are consistent with the conclusion that the assay is highly selective for a very primitive, totipotent, reconstituting hematopoietic stem cell and should therefore be particularly useful in future gene therapy-oriented research as well as for more basic studies of hematopoietic stem cell regulation and differentiation.
Similar articles
-
Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability.Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1968-72. doi: 10.1073/pnas.89.5.1968. Proc Natl Acad Sci U S A. 1992. PMID: 1311857 Free PMC article.
-
Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.Blood. 1996 Jun 1;87(11):4618-28. Blood. 1996. PMID: 8639830
-
Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.Exp Hematol. 1999 Sep;27(9):1418-27. doi: 10.1016/s0301-472x(99)00078-8. Exp Hematol. 1999. PMID: 10480433
-
Hematopoietic stem cells: inferences from in vivo assays.Stem Cells. 1997;15 Suppl 1:1-5. doi: 10.1002/stem.5530150802. Stem Cells. 1997. PMID: 9368318 Review.
-
Stem cell plasticity in muscle and bone marrow.Ann N Y Acad Sci. 2001 Jun;938:208-18; discussion 218-20. doi: 10.1111/j.1749-6632.2001.tb03591.x. Ann N Y Acad Sci. 2001. PMID: 11458510 Review.
Cited by
-
Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.J Clin Invest. 2006 Oct;116(10):2808-16. doi: 10.1172/JCI28310. J Clin Invest. 2006. PMID: 17016561 Free PMC article.
-
Clones assemble! The clonal complexity of blood during ontogeny and disease.Exp Hematol. 2020 Mar;83:35-47. doi: 10.1016/j.exphem.2020.01.009. Epub 2020 Jan 30. Exp Hematol. 2020. PMID: 32006606 Free PMC article. Review.
-
MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET Radiation.Stem Cells Transl Med. 2018 Jul;7(7):513-520. doi: 10.1002/sctm.17-0295. Epub 2018 Apr 14. Stem Cells Transl Med. 2018. PMID: 29656536 Free PMC article.
-
Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation.Stem Cells Transl Med. 2021 Mar;10(3):337-345. doi: 10.1002/sctm.20-0294. Epub 2020 Oct 15. Stem Cells Transl Med. 2021. PMID: 33058566 Free PMC article. Review.
-
Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates.Differentiation. 2013 Oct;86(3):77-86. doi: 10.1016/j.diff.2013.05.001. Epub 2013 Jun 19. Differentiation. 2013. PMID: 23790394 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical